1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Group A and Group C Meningococcal Polysaccharide Vaccine Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Group A and Group C Meningococcal Polysaccharide Vaccine by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Group A and Group C Meningococcal Polysaccharide Vaccine by Country/Region, 2018, 2022 & 2029
2.2 Group A and Group C Meningococcal Polysaccharide Vaccine Segment by Type
2.2.1 Class 1 Vaccine
2.2.2 Class II Vaccine
2.3 Group A and Group C Meningococcal Polysaccharide Vaccine Sales by Type
2.3.1 Global Group A and Group C Meningococcal Polysaccharide Vaccine Sales Market Share by Type (2018-2023)
2.3.2 Global Group A and Group C Meningococcal Polysaccharide Vaccine Revenue and Market Share by Type (2018-2023)
2.3.3 Global Group A and Group C Meningococcal Polysaccharide Vaccine Sale Price by Type (2018-2023)
2.4 Group A and Group C Meningococcal Polysaccharide Vaccine Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.5 Group A and Group C Meningococcal Polysaccharide Vaccine Sales by Application
2.5.1 Global Group A and Group C Meningococcal Polysaccharide Vaccine Sale Market Share by Application (2018-2023)
2.5.2 Global Group A and Group C Meningococcal Polysaccharide Vaccine Revenue and Market Share by Application (2018-2023)
2.5.3 Global Group A and Group C Meningococcal Polysaccharide Vaccine Sale Price by Application (2018-2023)
3 Global Group A and Group C Meningococcal Polysaccharide Vaccine by Company
3.1 Global Group A and Group C Meningococcal Polysaccharide Vaccine Breakdown Data by Company
3.1.1 Global Group A and Group C Meningococcal Polysaccharide Vaccine Annual Sales by Company (2018-2023)
3.1.2 Global Group A and Group C Meningococcal Polysaccharide Vaccine Sales Market Share by Company (2018-2023)
3.2 Global Group A and Group C Meningococcal Polysaccharide Vaccine Annual Revenue by Company (2018-2023)
3.2.1 Global Group A and Group C Meningococcal Polysaccharide Vaccine Revenue by Company (2018-2023)
3.2.2 Global Group A and Group C Meningococcal Polysaccharide Vaccine Revenue Market Share by Company (2018-2023)
3.3 Global Group A and Group C Meningococcal Polysaccharide Vaccine Sale Price by Company
3.4 Key Manufacturers Group A and Group C Meningococcal Polysaccharide Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Group A and Group C Meningococcal Polysaccharide Vaccine Product Location Distribution
3.4.2 Players Group A and Group C Meningococcal Polysaccharide Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Group A and Group C Meningococcal Polysaccharide Vaccine by Geographic Region
4.1 World Historic Group A and Group C Meningococcal Polysaccharide Vaccine Market Size by Geographic Region (2018-2023)
4.1.1 Global Group A and Group C Meningococcal Polysaccharide Vaccine Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Group A and Group C Meningococcal Polysaccharide Vaccine Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Group A and Group C Meningococcal Polysaccharide Vaccine Market Size by Country/Region (2018-2023)
4.2.1 Global Group A and Group C Meningococcal Polysaccharide Vaccine Annual Sales by Country/Region (2018-2023)
4.2.2 Global Group A and Group C Meningococcal Polysaccharide Vaccine Annual Revenue by Country/Region (2018-2023)
4.3 Americas Group A and Group C Meningococcal Polysaccharide Vaccine Sales Growth
4.4 APAC Group A and Group C Meningococcal Polysaccharide Vaccine Sales Growth
4.5 Europe Group A and Group C Meningococcal Polysaccharide Vaccine Sales Growth
4.6 Middle East & Africa Group A and Group C Meningococcal Polysaccharide Vaccine Sales Growth
5 Americas
5.1 Americas Group A and Group C Meningococcal Polysaccharide Vaccine Sales by Country
5.1.1 Americas Group A and Group C Meningococcal Polysaccharide Vaccine Sales by Country (2018-2023)
5.1.2 Americas Group A and Group C Meningococcal Polysaccharide Vaccine Revenue by Country (2018-2023)
5.2 Americas Group A and Group C Meningococcal Polysaccharide Vaccine Sales by Type
5.3 Americas Group A and Group C Meningococcal Polysaccharide Vaccine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Group A and Group C Meningococcal Polysaccharide Vaccine Sales by Region
6.1.1 APAC Group A and Group C Meningococcal Polysaccharide Vaccine Sales by Region (2018-2023)
6.1.2 APAC Group A and Group C Meningococcal Polysaccharide Vaccine Revenue by Region (2018-2023)
6.2 APAC Group A and Group C Meningococcal Polysaccharide Vaccine Sales by Type
6.3 APAC Group A and Group C Meningococcal Polysaccharide Vaccine Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Group A and Group C Meningococcal Polysaccharide Vaccine by Country
7.1.1 Europe Group A and Group C Meningococcal Polysaccharide Vaccine Sales by Country (2018-2023)
7.1.2 Europe Group A and Group C Meningococcal Polysaccharide Vaccine Revenue by Country (2018-2023)
7.2 Europe Group A and Group C Meningococcal Polysaccharide Vaccine Sales by Type
7.3 Europe Group A and Group C Meningococcal Polysaccharide Vaccine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Group A and Group C Meningococcal Polysaccharide Vaccine by Country
8.1.1 Middle East & Africa Group A and Group C Meningococcal Polysaccharide Vaccine Sales by Country (2018-2023)
8.1.2 Middle East & Africa Group A and Group C Meningococcal Polysaccharide Vaccine Revenue by Country (2018-2023)
8.2 Middle East & Africa Group A and Group C Meningococcal Polysaccharide Vaccine Sales by Type
8.3 Middle East & Africa Group A and Group C Meningococcal Polysaccharide Vaccine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Group A and Group C Meningococcal Polysaccharide Vaccine
10.3 Manufacturing Process Analysis of Group A and Group C Meningococcal Polysaccharide Vaccine
10.4 Industry Chain Structure of Group A and Group C Meningococcal Polysaccharide Vaccine
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Group A and Group C Meningococcal Polysaccharide Vaccine Distributors
11.3 Group A and Group C Meningococcal Polysaccharide Vaccine Customer
12 World Forecast Review for Group A and Group C Meningococcal Polysaccharide Vaccine by Geographic Region
12.1 Global Group A and Group C Meningococcal Polysaccharide Vaccine Market Size Forecast by Region
12.1.1 Global Group A and Group C Meningococcal Polysaccharide Vaccine Forecast by Region (2024-2029)
12.1.2 Global Group A and Group C Meningococcal Polysaccharide Vaccine Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Group A and Group C Meningococcal Polysaccharide Vaccine Forecast by Type
12.7 Global Group A and Group C Meningococcal Polysaccharide Vaccine Forecast by Application
13 Key Players Analysis
13.1 Walvax
13.1.1 Walvax Company Information
13.1.2 Walvax Group A and Group C Meningococcal Polysaccharide Vaccine Product Portfolios and Specifications
13.1.3 Walvax Group A and Group C Meningococcal Polysaccharide Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Walvax Main Business Overview
13.1.5 Walvax Latest Developments
13.2 Lanzhou Institute of Biological Products
13.2.1 Lanzhou Institute of Biological Products Company Information
13.2.2 Lanzhou Institute of Biological Products Group A and Group C Meningococcal Polysaccharide Vaccine Product Portfolios and Specifications
13.2.3 Lanzhou Institute of Biological Products Group A and Group C Meningococcal Polysaccharide Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Lanzhou Institute of Biological Products Main Business Overview
13.2.5 Lanzhou Institute of Biological Products Latest Developments
13.3 AIM Bio
13.3.1 AIM Bio Company Information
13.3.2 AIM Bio Group A and Group C Meningococcal Polysaccharide Vaccine Product Portfolios and Specifications
13.3.3 AIM Bio Group A and Group C Meningococcal Polysaccharide Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 AIM Bio Main Business Overview
13.3.5 AIM Bio Latest Developments
13.4 Sanofi Pasteur
13.4.1 Sanofi Pasteur Company Information
13.4.2 Sanofi Pasteur Group A and Group C Meningococcal Polysaccharide Vaccine Product Portfolios and Specifications
13.4.3 Sanofi Pasteur Group A and Group C Meningococcal Polysaccharide Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Sanofi Pasteur Main Business Overview
13.4.5 Sanofi Pasteur Latest Developments
13.5 GSK
13.5.1 GSK Company Information
13.5.2 GSK Group A and Group C Meningococcal Polysaccharide Vaccine Product Portfolios and Specifications
13.5.3 GSK Group A and Group C Meningococcal Polysaccharide Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 GSK Main Business Overview
13.5.5 GSK Latest Developments
13.6 Hualan Bio
13.6.1 Hualan Bio Company Information
13.6.2 Hualan Bio Group A and Group C Meningococcal Polysaccharide Vaccine Product Portfolios and Specifications
13.6.3 Hualan Bio Group A and Group C Meningococcal Polysaccharide Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Hualan Bio Main Business Overview
13.6.5 Hualan Bio Latest Developments
13.7 ZFSW
13.7.1 ZFSW Company Information
13.7.2 ZFSW Group A and Group C Meningococcal Polysaccharide Vaccine Product Portfolios and Specifications
13.7.3 ZFSW Group A and Group C Meningococcal Polysaccharide Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 ZFSW Main Business Overview
13.7.5 ZFSW Latest Developments
13.8 Changsheng
13.8.1 Changsheng Company Information
13.8.2 Changsheng Group A and Group C Meningococcal Polysaccharide Vaccine Product Portfolios and Specifications
13.8.3 Changsheng Group A and Group C Meningococcal Polysaccharide Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Changsheng Main Business Overview
13.8.5 Changsheng Latest Developments
13.9 Kanghua Bio
13.9.1 Kanghua Bio Company Information
13.9.2 Kanghua Bio Group A and Group C Meningococcal Polysaccharide Vaccine Product Portfolios and Specifications
13.9.3 Kanghua Bio Group A and Group C Meningococcal Polysaccharide Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Kanghua Bio Main Business Overview
13.9.5 Kanghua Bio Latest Developments
14 Research Findings and Conclusion
Table 1. Group A and Group C Meningococcal Polysaccharide Vaccine Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Group A and Group C Meningococcal Polysaccharide Vaccine Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Class 1 Vaccine
Table 4. Major Players of Class II Vaccine
Table 5. Global Group A and Group C Meningococcal Polysaccharide Vaccine Sales by Type (2018-2023) & (K Units)
Table 6. Global Group A and Group C Meningococcal Polysaccharide Vaccine Sales Market Share by Type (2018-2023)
Table 7. Global Group A and Group C Meningococcal Polysaccharide Vaccine Revenue by Type (2018-2023) & ($ million)
Table 8. Global Group A and Group C Meningococcal Polysaccharide Vaccine Revenue Market Share by Type (2018-2023)
Table 9. Global Group A and Group C Meningococcal Polysaccharide Vaccine Sale Price by Type (2018-2023) & (US$/Unit)
Table 10. Global Group A and Group C Meningococcal Polysaccharide Vaccine Sales by Application (2018-2023) & (K Units)
Table 11. Global Group A and Group C Meningococcal Polysaccharide Vaccine Sales Market Share by Application (2018-2023)
Table 12. Global Group A and Group C Meningococcal Polysaccharide Vaccine Revenue by Application (2018-2023)
Table 13. Global Group A and Group C Meningococcal Polysaccharide Vaccine Revenue Market Share by Application (2018-2023)
Table 14. Global Group A and Group C Meningococcal Polysaccharide Vaccine Sale Price by Application (2018-2023) & (US$/Unit)
Table 15. Global Group A and Group C Meningococcal Polysaccharide Vaccine Sales by Company (2018-2023) & (K Units)
Table 16. Global Group A and Group C Meningococcal Polysaccharide Vaccine Sales Market Share by Company (2018-2023)
Table 17. Global Group A and Group C Meningococcal Polysaccharide Vaccine Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Group A and Group C Meningococcal Polysaccharide Vaccine Revenue Market Share by Company (2018-2023)
Table 19. Global Group A and Group C Meningococcal Polysaccharide Vaccine Sale Price by Company (2018-2023) & (US$/Unit)
Table 20. Key Manufacturers Group A and Group C Meningococcal Polysaccharide Vaccine Producing Area Distribution and Sales Area
Table 21. Players Group A and Group C Meningococcal Polysaccharide Vaccine Products Offered
Table 22. Group A and Group C Meningococcal Polysaccharide Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Group A and Group C Meningococcal Polysaccharide Vaccine Sales by Geographic Region (2018-2023) & (K Units)
Table 26. Global Group A and Group C Meningococcal Polysaccharide Vaccine Sales Market Share Geographic Region (2018-2023)
Table 27. Global Group A and Group C Meningococcal Polysaccharide Vaccine Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Group A and Group C Meningococcal Polysaccharide Vaccine Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Group A and Group C Meningococcal Polysaccharide Vaccine Sales by Country/Region (2018-2023) & (K Units)
Table 30. Global Group A and Group C Meningococcal Polysaccharide Vaccine Sales Market Share by Country/Region (2018-2023)
Table 31. Global Group A and Group C Meningococcal Polysaccharide Vaccine Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Group A and Group C Meningococcal Polysaccharide Vaccine Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Group A and Group C Meningococcal Polysaccharide Vaccine Sales by Country (2018-2023) & (K Units)
Table 34. Americas Group A and Group C Meningococcal Polysaccharide Vaccine Sales Market Share by Country (2018-2023)
Table 35. Americas Group A and Group C Meningococcal Polysaccharide Vaccine Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Group A and Group C Meningococcal Polysaccharide Vaccine Revenue Market Share by Country (2018-2023)
Table 37. Americas Group A and Group C Meningococcal Polysaccharide Vaccine Sales by Type (2018-2023) & (K Units)
Table 38. Americas Group A and Group C Meningococcal Polysaccharide Vaccine Sales by Application (2018-2023) & (K Units)
Table 39. APAC Group A and Group C Meningococcal Polysaccharide Vaccine Sales by Region (2018-2023) & (K Units)
Table 40. APAC Group A and Group C Meningococcal Polysaccharide Vaccine Sales Market Share by Region (2018-2023)
Table 41. APAC Group A and Group C Meningococcal Polysaccharide Vaccine Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Group A and Group C Meningococcal Polysaccharide Vaccine Revenue Market Share by Region (2018-2023)
Table 43. APAC Group A and Group C Meningococcal Polysaccharide Vaccine Sales by Type (2018-2023) & (K Units)
Table 44. APAC Group A and Group C Meningococcal Polysaccharide Vaccine Sales by Application (2018-2023) & (K Units)
Table 45. Europe Group A and Group C Meningococcal Polysaccharide Vaccine Sales by Country (2018-2023) & (K Units)
Table 46. Europe Group A and Group C Meningococcal Polysaccharide Vaccine Sales Market Share by Country (2018-2023)
Table 47. Europe Group A and Group C Meningococcal Polysaccharide Vaccine Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Group A and Group C Meningococcal Polysaccharide Vaccine Revenue Market Share by Country (2018-2023)
Table 49. Europe Group A and Group C Meningococcal Polysaccharide Vaccine Sales by Type (2018-2023) & (K Units)
Table 50. Europe Group A and Group C Meningococcal Polysaccharide Vaccine Sales by Application (2018-2023) & (K Units)
Table 51. Middle East & Africa Group A and Group C Meningococcal Polysaccharide Vaccine Sales by Country (2018-2023) & (K Units)
Table 52. Middle East & Africa Group A and Group C Meningococcal Polysaccharide Vaccine Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Group A and Group C Meningococcal Polysaccharide Vaccine Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Group A and Group C Meningococcal Polysaccharide Vaccine Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Group A and Group C Meningococcal Polysaccharide Vaccine Sales by Type (2018-2023) & (K Units)
Table 56. Middle East & Africa Group A and Group C Meningococcal Polysaccharide Vaccine Sales by Application (2018-2023) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Group A and Group C Meningococcal Polysaccharide Vaccine
Table 58. Key Market Challenges & Risks of Group A and Group C Meningococcal Polysaccharide Vaccine
Table 59. Key Industry Trends of Group A and Group C Meningococcal Polysaccharide Vaccine
Table 60. Group A and Group C Meningococcal Polysaccharide Vaccine Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Group A and Group C Meningococcal Polysaccharide Vaccine Distributors List
Table 63. Group A and Group C Meningococcal Polysaccharide Vaccine Customer List
Table 64. Global Group A and Group C Meningococcal Polysaccharide Vaccine Sales Forecast by Region (2024-2029) & (K Units)
Table 65. Global Group A and Group C Meningococcal Polysaccharide Vaccine Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Group A and Group C Meningococcal Polysaccharide Vaccine Sales Forecast by Country (2024-2029) & (K Units)
Table 67. Americas Group A and Group C Meningococcal Polysaccharide Vaccine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Group A and Group C Meningococcal Polysaccharide Vaccine Sales Forecast by Region (2024-2029) & (K Units)
Table 69. APAC Group A and Group C Meningococcal Polysaccharide Vaccine Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Group A and Group C Meningococcal Polysaccharide Vaccine Sales Forecast by Country (2024-2029) & (K Units)
Table 71. Europe Group A and Group C Meningococcal Polysaccharide Vaccine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Group A and Group C Meningococcal Polysaccharide Vaccine Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Middle East & Africa Group A and Group C Meningococcal Polysaccharide Vaccine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Group A and Group C Meningococcal Polysaccharide Vaccine Sales Forecast by Type (2024-2029) & (K Units)
Table 75. Global Group A and Group C Meningococcal Polysaccharide Vaccine Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Group A and Group C Meningococcal Polysaccharide Vaccine Sales Forecast by Application (2024-2029) & (K Units)
Table 77. Global Group A and Group C Meningococcal Polysaccharide Vaccine Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Walvax Basic Information, Group A and Group C Meningococcal Polysaccharide Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 79. Walvax Group A and Group C Meningococcal Polysaccharide Vaccine Product Portfolios and Specifications
Table 80. Walvax Group A and Group C Meningococcal Polysaccharide Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 81. Walvax Main Business
Table 82. Walvax Latest Developments
Table 83. Lanzhou Institute of Biological Products Basic Information, Group A and Group C Meningococcal Polysaccharide Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 84. Lanzhou Institute of Biological Products Group A and Group C Meningococcal Polysaccharide Vaccine Product Portfolios and Specifications
Table 85. Lanzhou Institute of Biological Products Group A and Group C Meningococcal Polysaccharide Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 86. Lanzhou Institute of Biological Products Main Business
Table 87. Lanzhou Institute of Biological Products Latest Developments
Table 88. AIM Bio Basic Information, Group A and Group C Meningococcal Polysaccharide Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 89. AIM Bio Group A and Group C Meningococcal Polysaccharide Vaccine Product Portfolios and Specifications
Table 90. AIM Bio Group A and Group C Meningococcal Polysaccharide Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 91. AIM Bio Main Business
Table 92. AIM Bio Latest Developments
Table 93. Sanofi Pasteur Basic Information, Group A and Group C Meningococcal Polysaccharide Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 94. Sanofi Pasteur Group A and Group C Meningococcal Polysaccharide Vaccine Product Portfolios and Specifications
Table 95. Sanofi Pasteur Group A and Group C Meningococcal Polysaccharide Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 96. Sanofi Pasteur Main Business
Table 97. Sanofi Pasteur Latest Developments
Table 98. GSK Basic Information, Group A and Group C Meningococcal Polysaccharide Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 99. GSK Group A and Group C Meningococcal Polysaccharide Vaccine Product Portfolios and Specifications
Table 100. GSK Group A and Group C Meningococcal Polysaccharide Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 101. GSK Main Business
Table 102. GSK Latest Developments
Table 103. Hualan Bio Basic Information, Group A and Group C Meningococcal Polysaccharide Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 104. Hualan Bio Group A and Group C Meningococcal Polysaccharide Vaccine Product Portfolios and Specifications
Table 105. Hualan Bio Group A and Group C Meningococcal Polysaccharide Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 106. Hualan Bio Main Business
Table 107. Hualan Bio Latest Developments
Table 108. ZFSW Basic Information, Group A and Group C Meningococcal Polysaccharide Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 109. ZFSW Group A and Group C Meningococcal Polysaccharide Vaccine Product Portfolios and Specifications
Table 110. ZFSW Group A and Group C Meningococcal Polysaccharide Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 111. ZFSW Main Business
Table 112. ZFSW Latest Developments
Table 113. Changsheng Basic Information, Group A and Group C Meningococcal Polysaccharide Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 114. Changsheng Group A and Group C Meningococcal Polysaccharide Vaccine Product Portfolios and Specifications
Table 115. Changsheng Group A and Group C Meningococcal Polysaccharide Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 116. Changsheng Main Business
Table 117. Changsheng Latest Developments
Table 118. Kanghua Bio Basic Information, Group A and Group C Meningococcal Polysaccharide Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 119. Kanghua Bio Group A and Group C Meningococcal Polysaccharide Vaccine Product Portfolios and Specifications
Table 120. Kanghua Bio Group A and Group C Meningococcal Polysaccharide Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 121. Kanghua Bio Main Business
Table 122. Kanghua Bio Latest Developments
List of Figures
Figure 1. Picture of Group A and Group C Meningococcal Polysaccharide Vaccine
Figure 2. Group A and Group C Meningococcal Polysaccharide Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Group A and Group C Meningococcal Polysaccharide Vaccine Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Group A and Group C Meningococcal Polysaccharide Vaccine Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Group A and Group C Meningococcal Polysaccharide Vaccine Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Class 1 Vaccine
Figure 10. Product Picture of Class II Vaccine
Figure 11. Global Group A and Group C Meningococcal Polysaccharide Vaccine Sales Market Share by Type in 2022
Figure 12. Global Group A and Group C Meningococcal Polysaccharide Vaccine Revenue Market Share by Type (2018-2023)
Figure 13. Group A and Group C Meningococcal Polysaccharide Vaccine Consumed in Hospital
Figure 14. Global Group A and Group C Meningococcal Polysaccharide Vaccine Market: Hospital (2018-2023) & (K Units)
Figure 15. Group A and Group C Meningococcal Polysaccharide Vaccine Consumed in Clinic
Figure 16. Global Group A and Group C Meningococcal Polysaccharide Vaccine Market: Clinic (2018-2023) & (K Units)
Figure 17. Global Group A and Group C Meningococcal Polysaccharide Vaccine Sales Market Share by Application (2022)
Figure 18. Global Group A and Group C Meningococcal Polysaccharide Vaccine Revenue Market Share by Application in 2022
Figure 19. Group A and Group C Meningococcal Polysaccharide Vaccine Sales Market by Company in 2022 (K Units)
Figure 20. Global Group A and Group C Meningococcal Polysaccharide Vaccine Sales Market Share by Company in 2022
Figure 21. Group A and Group C Meningococcal Polysaccharide Vaccine Revenue Market by Company in 2022 ($ Million)
Figure 22. Global Group A and Group C Meningococcal Polysaccharide Vaccine Revenue Market Share by Company in 2022
Figure 23. Global Group A and Group C Meningococcal Polysaccharide Vaccine Sales Market Share by Geographic Region (2018-2023)
Figure 24. Global Group A and Group C Meningococcal Polysaccharide Vaccine Revenue Market Share by Geographic Region in 2022
Figure 25. Americas Group A and Group C Meningococcal Polysaccharide Vaccine Sales 2018-2023 (K Units)
Figure 26. Americas Group A and Group C Meningococcal Polysaccharide Vaccine Revenue 2018-2023 ($ Millions)
Figure 27. APAC Group A and Group C Meningococcal Polysaccharide Vaccine Sales 2018-2023 (K Units)
Figure 28. APAC Group A and Group C Meningococcal Polysaccharide Vaccine Revenue 2018-2023 ($ Millions)
Figure 29. Europe Group A and Group C Meningococcal Polysaccharide Vaccine Sales 2018-2023 (K Units)
Figure 30. Europe Group A and Group C Meningococcal Polysaccharide Vaccine Revenue 2018-2023 ($ Millions)
Figure 31. Middle East & Africa Group A and Group C Meningococcal Polysaccharide Vaccine Sales 2018-2023 (K Units)
Figure 32. Middle East & Africa Group A and Group C Meningococcal Polysaccharide Vaccine Revenue 2018-2023 ($ Millions)
Figure 33. Americas Group A and Group C Meningococcal Polysaccharide Vaccine Sales Market Share by Country in 2022
Figure 34. Americas Group A and Group C Meningococcal Polysaccharide Vaccine Revenue Market Share by Country in 2022
Figure 35. Americas Group A and Group C Meningococcal Polysaccharide Vaccine Sales Market Share by Type (2018-2023)
Figure 36. Americas Group A and Group C Meningococcal Polysaccharide Vaccine Sales Market Share by Application (2018-2023)
Figure 37. United States Group A and Group C Meningococcal Polysaccharide Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 38. Canada Group A and Group C Meningococcal Polysaccharide Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 39. Mexico Group A and Group C Meningococcal Polysaccharide Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 40. Brazil Group A and Group C Meningococcal Polysaccharide Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 41. APAC Group A and Group C Meningococcal Polysaccharide Vaccine Sales Market Share by Region in 2022
Figure 42. APAC Group A and Group C Meningococcal Polysaccharide Vaccine Revenue Market Share by Regions in 2022
Figure 43. APAC Group A and Group C Meningococcal Polysaccharide Vaccine Sales Market Share by Type (2018-2023)
Figure 44. APAC Group A and Group C Meningococcal Polysaccharide Vaccine Sales Market Share by Application (2018-2023)
Figure 45. China Group A and Group C Meningococcal Polysaccharide Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 46. Japan Group A and Group C Meningococcal Polysaccharide Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 47. South Korea Group A and Group C Meningococcal Polysaccharide Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 48. Southeast Asia Group A and Group C Meningococcal Polysaccharide Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 49. India Group A and Group C Meningococcal Polysaccharide Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 50. Australia Group A and Group C Meningococcal Polysaccharide Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 51. China Taiwan Group A and Group C Meningococcal Polysaccharide Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 52. Europe Group A and Group C Meningococcal Polysaccharide Vaccine Sales Market Share by Country in 2022
Figure 53. Europe Group A and Group C Meningococcal Polysaccharide Vaccine Revenue Market Share by Country in 2022
Figure 54. Europe Group A and Group C Meningococcal Polysaccharide Vaccine Sales Market Share by Type (2018-2023)
Figure 55. Europe Group A and Group C Meningococcal Polysaccharide Vaccine Sales Market Share by Application (2018-2023)
Figure 56. Germany Group A and Group C Meningococcal Polysaccharide Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 57. France Group A and Group C Meningococcal Polysaccharide Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 58. UK Group A and Group C Meningococcal Polysaccharide Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 59. Italy Group A and Group C Meningococcal Polysaccharide Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 60. Russia Group A and Group C Meningococcal Polysaccharide Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 61. Middle East & Africa Group A and Group C Meningococcal Polysaccharide Vaccine Sales Market Share by Country in 2022
Figure 62. Middle East & Africa Group A and Group C Meningococcal Polysaccharide Vaccine Revenue Market Share by Country in 2022
Figure 63. Middle East & Africa Group A and Group C Meningococcal Polysaccharide Vaccine Sales Market Share by Type (2018-2023)
Figure 64. Middle East & Africa Group A and Group C Meningococcal Polysaccharide Vaccine Sales Market Share by Application (2018-2023)
Figure 65. Egypt Group A and Group C Meningococcal Polysaccharide Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 66. South Africa Group A and Group C Meningococcal Polysaccharide Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 67. Israel Group A and Group C Meningococcal Polysaccharide Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 68. Turkey Group A and Group C Meningococcal Polysaccharide Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 69. GCC Country Group A and Group C Meningococcal Polysaccharide Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 70. Manufacturing Cost Structure Analysis of Group A and Group C Meningococcal Polysaccharide Vaccine in 2022
Figure 71. Manufacturing Process Analysis of Group A and Group C Meningococcal Polysaccharide Vaccine
Figure 72. Industry Chain Structure of Group A and Group C Meningococcal Polysaccharide Vaccine
Figure 73. Channels of Distribution
Figure 74. Global Group A and Group C Meningococcal Polysaccharide Vaccine Sales Market Forecast by Region (2024-2029)
Figure 75. Global Group A and Group C Meningococcal Polysaccharide Vaccine Revenue Market Share Forecast by Region (2024-2029)
Figure 76. Global Group A and Group C Meningococcal Polysaccharide Vaccine Sales Market Share Forecast by Type (2024-2029)
Figure 77. Global Group A and Group C Meningococcal Polysaccharide Vaccine Revenue Market Share Forecast by Type (2024-2029)
Figure 78. Global Group A and Group C Meningococcal Polysaccharide Vaccine Sales Market Share Forecast by Application (2024-2029)
Figure 79. Global Group A and Group C Meningococcal Polysaccharide Vaccine Revenue Market Share Forecast by Application (2024-2029)
❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
